BioArctic AB (STU:B9A) Change In Receivables : €0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB Change In Receivables?

BioArctic AB's change in receivables for the quarter that ended in Mar. 2024 was €0.00 Mil. It means BioArctic AB's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

BioArctic AB's change in receivables for the fiscal year that ended in Dec. 2023 was €-1.07 Mil. It means BioArctic AB's Accounts Receivable increased by €1.07 Mil from Dec. 2022 to Dec. 2023 .

BioArctic AB's Accounts Receivable for the quarter that ended in Mar. 2024 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioArctic AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioArctic AB's liquidation value for the three months ended in Mar. 2024 was €30.70 Mil.

BioArctic AB Change In Receivables Historical Data

The historical data trend for BioArctic AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Change In Receivables Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

41.33

2.27

-0.50

-0.22

-1.07

BioArctic AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

BioArctic AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

BioArctic AB (STU:B9A) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioArctic AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	2.619	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, BioArctic AB's accounts receivable are only considered to be worth 75% of book value:

BioArctic AB's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	43.39	-	12.69	+	0.75 * 0	+	0.5 * 0
=	30.70

BioArctic AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB (STU:B9A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BRCTF:USA BIOA B:Sweden 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (STU:B9A) Headlines

No Headlines